Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Fouzia N. Abubacker"'
Autor:
Sharon Anbumalar Lionel, Sushil Selvarajan, Anu Korula, Uday Kulkarni, Anup Devasia, Fouzia N. Abubacker, Aby Abraham, Vikram Mathews, Kavitha M. Lakshmi, Biju George
Publikováno v:
Indian Journal of Hematology and Blood Transfusion.
Autor:
Sushil Selvarajan, Biju George, Anu Korula, Vikram Mathews, Anup J. Devasia, Aby Abraham, Sharon Lionel, Eunice Sindhuvi, Kavitha M Lakshmi, Uday Kulkarni, Fouzia N. Abubacker
Publikováno v:
Transplantation and cellular therapy. 27(5)
Allogeneic hematopoietic stem cell transplantation (HSCT) using fludarabine (Flu)-based conditioning regimens are being increasingly being used in patients with aplastic anemia (AA). We describe an antithymocyte globulin (ATG)-free conditioning regim
Autor:
Anu Korula, Kavitha M Lakshmi, Susmitha Perumalla, Alok Srivastava, Aby Abraham, Biju George, Balaji Veeraraghavan, Fouzia N. Abubacker, Vikram Mathews, Anup J. Devasia, Shalini Anandan
Publikováno v:
Transplant Infectious Disease. 22
Background With the increasing incidence of multidrug-resistant (MDR) organisms and high mortality rates associated with these infections, we describe the spectrum of the major drug-resistant pathogens identified in fecal surveillance, and re-visit t
Autor:
Aby Abraham, Alok Srivastava, Punit Jain, Fouzia N. Abubacker, Anu Korula, Biju George, Vikram Mathews, Joy John Mammen, Auro Viswabandya, Abhijeet Ganapule
Publikováno v:
Blood Coagulation & Fibrinolysis. 28:171-175
Glanzmann's thrombasthenia is a rare platelet function disorder with an autosomal recessive pattern of inheritance. Achieving haemostasis in such patients who undergo surgical procedures always poses a significant challenge. Herein we report six case
Autor:
Aby Abraham, Kavitha M Lakshmi, Anu Korula, Biju George, Vikram Mathews, Alok Srivastava, Uday Kulkarni, Fouzia N. Abubacker, Anup J. Devasia
Publikováno v:
British journal of haematologyReferences. 188(6)
Treatment of Hodgkin lymphoma (HL) has evolved with risk-stratified therapy based on PET-CT scan at multiple timepoints. In a resource constraint setting even a single PET-CT scan ($400) is inaccessible to many patients, who are re-assessed with only
Autor:
Biju George, Vikram Mathews, Aby Abraham, Uday Kulkarni, Fouzia N. Abubacker, Anu Korula, Sharon Lionel, Anup J. Devasia, Alok Srivastava, Kavitha M Lakshmi
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:S213-S214
Introduction The access to hematopoietic stem cell transplant [HSCT] for children lacking a matched sibling donor has vastly improved with the introduction of haplo-identical transplant using post-transplant cyclophosphamide(PTCy). There is limited d
Autor:
Auro Viswabandya, Punit Jain, Aby Abraham, Anu Korula, Biju George, Vivi M. Srivastava, Vikram Mathews, Kavitha M Lakshmi, Abhijeet Ganapule, Usha Sitaram, Chepsy C Philip, Ansu Abu Alex, Fouzia N. Abubacker, Alok Srivastava, Poonkuzhali Balasubramanian
Publikováno v:
British Journal of Haematology
Summary The management of acute myeloid leukaemia (AML) in India remains a challenge. In a two‐year prospective study at our centre there were 380 newly diagnosed AML (excluding acute promyelocytic leukaemia, AML‐M3) patients. The median age of n
Autor:
Kavitha M Lakshmi, O C Abraham, Priscilla Rupali, Auro Viswabandya, George M. Varghese, Anu Korula, Aby Abraham, Biju George, Vikram Mathews, Joy Sarojini Michael, Fouzia N. Abubacker, Alok Srivastava
Publikováno v:
Mycoses. 60(10)
Summary The incidence of invasive fungal infections (IFI) is believed to be higher in patients with acute myeloid leukaemia (AML) undergoing chemotherapy in non-HEPA-filtered rooms. The aim of this study is to review the incidence of IFI in a large c
Autor:
Poonkuzhali Balasubramanian, Sharon Lionel, Aby Abraham, Anup J. Devasia, Alok Srivastava, Anu Korula, Fouzia N. Abubacker, Uday Kulkarni, Biju George, Vikram Mathews, Arvind Venkatraman
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:S353
There is paucity of data from developing countries on the clinical profile, symptom burden and treatment access in patients with primary myelofibrosis (PMF).
Autor:
Hervé Chambost, Anthony K.C. Chan, Natalya Kavardakova, Thierry Lambert, Leonid Dubey, Manuel Carcao, Anna Klukowska, John K. Wu, Yves Gruel, Christoph Königs, Sunil Lohade, Jonathan M. Ducore, Fouzia N. Abubacker, Annie Borel-Derlon, Marina Abashidze, Raina Liesner, Vladimir Vdovin, Valentin Turea, Michael Gattens, Mohamed El Khorassani, Olga Aleinikova, Carmen Altisent, Marianne Sigaud, Mark Belletrutti
Publikováno v:
Blood. 128:327-327
Background Studies have shown that the incidence of inhibitor development varies between FVIII concentrates, with some suggesting that recombinant FVIII (rFVIII) concentrates produced in hamster cell lines pose a greater risk of inhibitor development